Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.

Weight-loss drugs are transforming health care and Wall Street, but exciting prospects don’t necessarily mean a company is a good investment.

Such vulnerabilities reveal systemic weaknesses, especially when drugs like Wegovy should only be prescribed under close clinical supervision. A significant concern is the prescription of Wegovy ...

The Biden administration on Friday released its next round of prescription drugs selected for Medicare price negotiations, ...

CBS News Miami investigates the financial hurdles surrounding these medications and explores alternatives that may offer a ...

WASHINGTON — Popular weight loss and ... the popular anti-obesity medications. The savings on the 25 drugs stem from a new ...

Oprah Winfrey gained a new perspective. The media mogul, throughout her career, has been candid about her journey with weight, and that remained true as she began using weight loss medications.

Drug prices are up for negotiation on 15 Medicare Part D prescription drugs, including popular weight loss drugs such as Ozempic.

If successful, the result could be lower Medicare Part D prices for drugs used to create a variety of conditions, such as ...

The Biden administration said Medicare will negotiate discounts with drug companies on 15 drugs prescribed to treat cancer, ...

Novo Nordisk (NYSE:NVO) shares are rallying 6.87% to $86.67 as of 10:27 AM ET Friday, after the company reported promising trial results for its new obesity drug ... to 22% weight loss over ...

The Biden administration on Friday released its next round of prescription drugs selected for Medicare price negotiations, ...